Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.

Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.

Sermorelin safety profile is favorable: most users experience no serious adverse effects. Common mild side effects: water retention (30-40%), joint pain/arthralgia (10-15%), carpal tunnel syndrome (2-5%), numbness/tingling (5-10%), transient cortisol elevation (self-resolving). Serious adverse effects are rare: no documented cancers, cardiovascular events, or liver toxicity in published research. Contraindications: active cancer (relative), uncontrolled diabetes, severe hypertension. Long-term safety data (24+ months) is limited; cycling is recommended.

Common Mild Side Effects

Comprehensive content covering common mild side effects.

Water Retention Management

Comprehensive content covering water retention management.

Joint Pain and Arthralgia

Comprehensive content covering joint pain and arthralgia.

Carpal Tunnel Syndrome

Comprehensive content covering carpal tunnel syndrome.

Numbness and Tingling Sensations

Comprehensive content covering numbness and tingling sensations.

Glucose Metabolism Effects

Comprehensive content covering glucose metabolism effects.

Cortisol and ACTH Changes

Comprehensive content covering cortisol and acth changes.

Serious Adverse Events (Rare)

Comprehensive content covering serious adverse events (rare).

Cancer Risk Considerations

Comprehensive content covering cancer risk considerations.

Long-Term Safety Monitoring

Comprehensive content covering long-term safety monitoring.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Particle Peptides

Independently HPLC-tested, transparent COAs, comprehensive product range.

Browse Particle Peptides →

Limitless Life Nootropics

Premium research peptides with strong customer support and verified purity.

Browse Limitless Life →

Frequently Asked Questions

Is sermorelin safe overall?

Yes. Safety profile is favorable for short-term use. Most side effects are mild and dose-dependent. Long-term (24+ month) safety is incompletely characterized.

What are the most common side effects?

Water retention (30-40%), joint pain (10-15%), carpal tunnel (2-5%), numbness/tingling (5-10%). Most resolve within 1-2 weeks of discontinuation.

Does sermorelin increase cancer risk?

No evidence of increased cancer risk in published studies. GH itself has been questioned in some contexts, but sermorelin's gentle GH stimulation is lower-risk than exogenous HGH.

Can sermorelin cause diabetes?

Sermorelin may slightly impair glucose tolerance in some users (GH is diabetogenic at high doses). Minimal risk at research doses; monitor glucose if diabetic.

What should I do if I get carpal tunnel?

Reduce dose by 25-50%, take nightly breaks (2-3 days off per week), use wrist splinting, consider discontinuation if severe. Symptoms resolve within 1-2 weeks after stopping.

Who shouldn't use sermorelin?

Active cancer (relative contraindication), uncontrolled diabetes, severe untreated hypertension. Otherwise-healthy individuals tolerate sermorelin well.